Related references
Note: Only part of the references are listed.Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
Diana Llopiz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma
Haiyan Ma et al.
CANCER SCIENCE (2019)
TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis
Aizhang Xu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2
Jing-hui Tian et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Wnt-β-catenin signalling in liver development, health and disease
Maria J. Perugorria et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice
Lu Zong et al.
NATURE COMMUNICATIONS (2019)
Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
Jingying Zhou et al.
GUT (2018)
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models
Luca Quagliata et al.
LABORATORY INVESTIGATION (2018)
Low expression level of HMBOX1 in high-grade serous ovarian cancer accelerates cell proliferation by inhibiting cell apoptosis
Yun-Liang Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling
Jianting Long et al.
CANCER LETTERS (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
被撤回的出版物: IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma (Retracted article. See vol. 123, pg. 1118, 2022)
Zi Yin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway
Xiao Fu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of beta-catenin activation
Shirley Abitbol et al.
JOURNAL OF HEPATOLOGY (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
HMBOX1 in hepatocytes attenuates LPS/D-GalN-induced liver injury by inhibiting macrophage infiltration and activation
Hengli Zhao et al.
MOLECULAR IMMUNOLOGY (2018)
Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
Min Yu et al.
MOLECULAR THERAPY (2018)
CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
Stephen J. Bagley et al.
NEURO-ONCOLOGY (2018)
Homeobox containing 1 inhibits liver cancer progression by promoting autophagy as well as inhibiting stemness and immune escape
Hengli Zhao et al.
ONCOLOGY REPORTS (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Cancer-associated fibroblasts induce PDL1+neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
Yusheng Cheng et al.
CELL DEATH & DISEASE (2018)
14-3-3 zeta delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes
Xiaochen Wang et al.
CELL DEATH & DISEASE (2018)
Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors
Yang Yang et al.
CELL DEATH & DISEASE (2018)
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
Tian Fang et al.
NATURE COMMUNICATIONS (2018)
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
Yao Wang et al.
ONCOIMMUNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Regulation of Macrophage Activation and Polarization by HCC-Derived Exosomal lncRNA TUC339
Xue Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Differential regulation of the Wnt/β-catenin pathway by hepatitis C virus recombinants expressing core from various genotypes
Stephanie Aicher et al.
SCIENTIFIC REPORTS (2018)
Sorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinoma
Jun Li et al.
CANCER BIOLOGY & THERAPY (2018)
Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
Xingliang Guo et al.
FRONTIERS IN PHARMACOLOGY (2018)
Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction
Yinli Yang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Differential expression of plasma microRNA-125b in hepatitis B virus-related liver diseases and diagnostic potential for hepatitis B virus-induced hepatocellular carcinoma
Shanshan Chen et al.
HEPATOLOGY RESEARCH (2017)
Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis
Wantae Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma
Wenhui Wang et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Prospero-Related Homeobox 1 Drives Angiogenesis of Hepatocellular Carcinoma Through Selectively Activating Interleukin-8 Expression
Yanfeng Liu et al.
HEPATOLOGY (2017)
Virus-induced hepatocellular carcinoma with special emphasis on HBV
Ming Wang et al.
HEPATOLOGY INTERNATIONAL (2017)
MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1
Tong Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma
Miao Yu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion
Jingyi Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition
Hong-bo Huan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e5p/ MAPK/NFAT5 pathway
Xian Qin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma
Chunlin Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC
Qiuju Han et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models
Zhen Lu et al.
JOURNAL OF HEPATOLOGY (2017)
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
Austin G. Duffy et al.
JOURNAL OF HEPATOLOGY (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Bridging to liver transplantation in HCC patients
Dagmar Kollmann et al.
LANGENBECKS ARCHIVES OF SURGERY (2017)
Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma
Hao-Tu Zhu et al.
LIVER INTERNATIONAL (2017)
Homeobox-containing protein 1 loss is associated with clinicopathological performance in glioma
Ping Zhang et al.
MOLECULAR MEDICINE REPORTS (2017)
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
Gonzalo Sapisochin et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Systemic Therapy for Hepatocellular Carcinoma: 2017 Update
Masatoshi Kudo
ONCOLOGY (2017)
Nifuroxazide prompts antitumor immune response of TCL-loaded DC in mice with orthotopically-implanted hepatocarcinoma
Tiesuo Zhao et al.
ONCOLOGY REPORTS (2017)
STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury
Mitsuhiko Abe et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients
Kun Li et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma
Wei Xu et al.
SCIENTIFIC REPORTS (2017)
MicroRNA profile in HBV-induced infection and hepatocellular carcinoma
Guanyu Wang et al.
BMC CANCER (2017)
The Biology of Cancer Exosomes: Insights and New Perspectives
Carolina F. Ruivo et al.
CANCER RESEARCH (2017)
Modulation of Wnt signaling pathway by hepatitis B virus
Muhammad Daud et al.
ARCHIVES OF VIROLOGY (2017)
Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma
Shao-jun Zhou et al.
CELL DEATH AND DIFFERENTIATION (2017)
Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma
Mengxi Huang et al.
CANCER LETTERS (2017)
MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway
Wenhua Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis
Laura M. Jones et al.
CANCER RESEARCH (2016)
Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma
Juan Gao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells
Ronghua Wang et al.
ONCOTARGET (2016)
TLR4 signaling promotes a COX-2/PGE(2)/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells
Ang Lin et al.
ONCOIMMUNOLOGY (2016)
Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma
Yinli Yang et al.
CANCER BIOLOGY & THERAPY (2016)
HBx mutations promote hepatoma cell migration through the Wnt/-catenin signaling pathway
Zhen Chen et al.
CANCER SCIENCE (2016)
Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival
Sonja M. Woermann et al.
GASTROENTEROLOGY (2016)
Tumor-Derived Exosomes Elicit Tumor Suppression in Murine Hepatocellular Carcinoma Models and Humans In Vitro
Quan Rao et al.
HEPATOLOGY (2016)
Octamer 4/MicroRNA-1246 Signaling Axis Drives Wnt/β-Catenin Activation in Liver Cancer Stem Cells
Stella Chai et al.
HEPATOLOGY (2016)
Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro
Zhen Qu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122
Hong-Wei Liang et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatitis B Virus and DNA Stimulation Trigger a Rapid Innate Immune Response through NF-κB
Masato Yoneda et al.
JOURNAL OF IMMUNOLOGY (2016)
Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma
Fangyu Zhu et al.
MEDICAL ONCOLOGY (2016)
miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway
Xuemin Liu et al.
ONCOLOGY REPORTS (2016)
Dendritic Cells and Cancer Immunity
Alycia Gardner et al.
TRENDS IN IMMUNOLOGY (2016)
Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
J-t Cheng et al.
ONCOGENESIS (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
β-Catenin Promotes Regulatory T-cell Responses in Tumors by Inducing Vitamin A Metabolism in Dendritic Cells
Yuan Hong et al.
CANCER RESEARCH (2015)
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs
Mian He et al.
CARCINOGENESIS (2015)
miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression
Xiaoxia Sun et al.
CELL CYCLE (2015)
The Long Noncoding RNA IncTCF7 Promotes Self-Renewal of Human Liver Cancer Stem Cells through Activation of Wnt Signaling
Yanying Wang et al.
CELL STEM CELL (2015)
Recurrence of hepatocellular carcinoma after liver transplantation: an update
Alessandra Mazzola et al.
FUTURE ONCOLOGY (2015)
β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis
Satdarshan Pal Monga
GASTROENTEROLOGY (2015)
Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches
Tim F. Greten et al.
GUT (2015)
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Immunological landscape and immunotherapy of hepatocellular carcinoma
Jesus Prieto et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation
Y. Liu et al.
ONCOGENE (2015)
β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10
Chunmei Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis
Ming Geng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma
Shan-Shan Jiang et al.
ONCOTARGET (2015)
NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
Cheng Sun et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas
Giuliana Amaddeo et al.
GUT (2015)
Macrophage-secreted IL-8 induces-epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway
Xiu-Tao Fu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
HOXA7 stimulates human hepatocellular carcinoma proliferation through cyclin E1/CDK2
Yuehui Li et al.
ONCOLOGY REPORTS (2015)
Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9
Yuyi Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Phosphorothioate modification of the TLR9 ligand CpG ODN inhibits poly(I:C)-induced apoptosis of hepatocellular carcinoma by entry blockade
Yuyi Zhang et al.
CANCER LETTERS (2014)
Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib
Kai Mao et al.
CANCER LETTERS (2014)
β-Catenin Activation in a Novel Liver Progenitor Cell Type Is Sufficient to Cause Hepatocellular Carcinoma and Hepatoblastoma
Sharada Mokkapati et al.
CANCER RESEARCH (2014)
Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
Huiping Gao et al.
CLINICAL CANCER RESEARCH (2014)
Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
Shanshan Wan et al.
GASTROENTEROLOGY (2014)
Long Noncoding RNA HOTTIP/HOXA13 Expression is Associated With Disease Progression and Predicts Outcome in Hepatocellular Carcinoma Patients
Luca Quagliata et al.
HEPATOLOGY (2014)
hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo
Wen Jiang et al.
IMMUNOBIOLOGY (2014)
Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway
Qing Xie et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma
Xiaozhou Yu et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
NK Cells Are the Crucial Antitumor Mediators When STAT3-Mediated Immunosuppression Is Blocked in Hepatocellular Carcinoma
Qiangjun Sui et al.
JOURNAL OF IMMUNOLOGY (2014)
β-Catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8+ T cells
Xinjun Liang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
HOX genes and their role in the development of human cancers
Seema Bhatlekar et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Overexpression of HOXA13 as a Potential Marker for Diagnosis and Poor Prognosis of Hepatocellular Carcinoma
Ting-Ting Pan et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2014)
MicroRNAs Associated With HBV Infection And HBV-related HCC
Kun-Lin Xie et al.
THERANOSTICS (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
The Efficacy of Cytokine-Induced Killer Cell Infusion as an Adjuvant Therapy for Postoperative Hepatocellular Carcinoma Patients
Ke Pan et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Cellular and molecular mechanisms of hepatocellular carcinoma: an update
Rajagopal N. Aravalli et al.
ARCHIVES OF TOXICOLOGY (2013)
CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
Patrick A. Ott et al.
CLINICAL CANCER RESEARCH (2013)
hIFN-α gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function
W. Jiang et al.
GENE THERAPY (2013)
Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC
Mervat El Ansary et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2013)
Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions via Reverse Hepatocellular Carcinoma-Induced Immune Suppression
Xiaoxia Sun et al.
MOLECULAR CANCER THERAPEUTICS (2013)
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma
Pengyuan Yang et al.
CANCER CELL (2012)
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dianne H. Dapito et al.
CANCER CELL (2012)
miR-30c-1*promotes natural killer cell cytotoxicity against human hepatoma cells by targeting the transcription factor HMBOX1
Jiuyu Gong et al.
CANCER SCIENCE (2012)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
Fujimasa Tada et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro
Li-Hong Lv et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Inflammation and Cancer: A Comparative View
Wallace B. Morrison
JOURNAL OF VETERINARY INTERNAL MEDICINE (2012)
Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B
Eric T. T. L. Tjwa et al.
JOURNAL OF HEPATOLOGY (2011)
The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma
Ludwig Wilkens et al.
VIRCHOWS ARCHIV (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Serum microRNA Profiles Serve as Novel Biomarkers for HBV Infection and Diagnosis of HBV-Positive Hepatocarcinoma
Li-Min Li et al.
CANCER RESEARCH (2010)
Toll-like receptors 2/4 agonists: a potential strategy for preventing invasion and metastasis of hepatocellular carcinoma
Pengfei Yu et al.
GUT (2010)
Adiponectin Antagonizes the Oncogenic Actions of Leptin in Hepatocellular Carcinogenesis
Dipali Sharma et al.
HEPATOLOGY (2010)
The Immunoregulatory Role of CD244 in Chronic Hepatitis B Infection and its Inhibitory Potential on Virus-Specific CD8+T-cell Function
Bijan Raziorrouh et al.
HEPATOLOGY (2010)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Adjuvants for cancer vaccines
Thomas W. Dubensky et al.
SEMINARS IN IMMUNOLOGY (2010)
Recombinant Expression of a Novel Human Transcriptional Repressor HMBOX1 and Preparation of Anti-HMBOX1 Monoclonal Antibody
Jun Dai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Specific Mutations in the Enhancer II/Core Promoter/Precore Regions of Hepatitis B Virus Subgenotype C2 in Korean Patients With Hepatocellular Carcinoma
Ja Kyung Kim et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: A tissue microarray analysis of 4,387 tissue samples
Daniel Baumhoer et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous α fetoprotein in mice
Wei Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN
Xiaoxia Sun et al.
CANCER LETTERS (2008)
Functional characterization of interleukin-15 gene transduction into the human natural killer cell line NKL
W. Jiang et al.
CYTOTHERAPY (2008)
Hepatitis B Virus X Protein Affects S Phase Progression Leading to Chromosome Segregation Defects by Binding to Damaged DNA Binding Protein 1
Silvia Martin-Lluesma et al.
HEPATOLOGY (2008)
Characterization of the innate immune signalling pathways in hepatocyte cell lines
S. Preiss et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Activation of hepatic stem cell marker EpCAM by Wnt-β-catenin signaling in hepatocellular carcinoma
Taro Yamashita et al.
CANCER RESEARCH (2007)
Classification and nomenclature of all human homeobox genes
Peter W. H. Holland et al.
BMC BIOLOGY (2007)
TLR3 signaling in a hepatoma cell line is skewed towards apoptosis
Elina Khvalevsky et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
A homeobox protein, Prox1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinoma
Masayuki Shimoda et al.
CLINICAL CANCER RESEARCH (2006)
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides
LH Butterfield et al.
CLINICAL CANCER RESEARCH (2006)
Isolation and functional analysis of human HMBOX1, a homeobox containing protein with transcriptional repressor activity
S. Chen et al.
CYTOGENETIC AND GENOME RESEARCH (2006)
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
M Kortylewski et al.
NATURE MEDICINE (2005)
Homeobox gene expression in cancer: Insights from developmental regulation and deregulation
S Samuel et al.
EUROPEAN JOURNAL OF CANCER (2005)
Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma
GG Chen et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma
KW Chi et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Deregulated homeobox gene expression in cancer: Cause or consequence?
C Abate-Shen
NATURE REVIEWS CANCER (2002)
X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis
JY Diao et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2001)
X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway
JY Diao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways
P Arbuthnot et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Share Paper
